Published amid growing concern over non-tuberculous mycobacteria (NTM), and other opportunistic waterborne pathogens, NETB 2024/03 recognises the critical role of point-of-use (POU) filters play in protecting vulnerable patients. The guidance sets higher standards for how filters are validated, deployed, and managed, while also recommending a precautionary approach: filters should now be used proactively in very high-risk areas, not only as a reactive measure following out-of-specification results or clinical infections.
T-safe360 has been designed to help NHS estates and IPC teams meet these requirements with confidence. Built around five core pillars, it provides a complete, future-ready strategy:
- Complete range for all outlets – the UK’s widest range of POU filters, validated as sterilising grade and proven for full life cycle performance.
- Gold-standard validation – testing to ASTM F838 and beyond, with full life cycle retention against clinically relevant pathogens, meeting the requirements of NETB 2024/03.
- Service-led deployment – regional teams delivering rapid response, rollouts, health checks, and on-site support.
- Embedded governance – structured policies and oversight aligned with NETB 2024/03, ensuring sustainable compliance and audit readiness.
- Digital compliance – FilterHub, T-safe’s compliance platform, tracking filter use, sample results, and remedial actions in real time
Stephen McCreanor, Managing director of T-safe UK, said: “NETB 2024/03 is a turning point. It acknowledges that POU filters are no longer just a reactive measure but a proactive safeguard for the most vulnerable patients. With T-safe360, we’ve created a framework that goes beyond the filter itself. It’s about giving hospitals confidence that their waterborne infection control measures are both effective and compliant.”
With T-safe360 now rolling out nationwide, NHS hospitals gain access to a complete strategy for POU filters in waterborne infection control.
T-safe
T: 0300 125 6050
E: sales.uk@t-safe.com
www.t-safe.com